Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Alper Ö"'
Autor:
Ott Robert, Öner Alper Ö, Bellé Paul Hermann, Borowski Finja, Schmitz Klaus-Peter, Stiehm Michael
Publikováno v:
Current Directions in Biomedical Engineering, Vol 7, Iss 2, Pp 605-608 (2021)
Mitral regurgitation (MR) is the second most frequent indication for heart valve surgery and catheter interventions. According to European and US-American guidelines, transcatheter mitral valve repair in general and transcatheter edge-to-edge repair
Externí odkaz:
https://doaj.org/article/e2af79eb6ef24390be689843a6f928f1
Autor:
Ott Robert, Kaule Sebastian, Großmann Swen, Stiehm Michael, Schmitz Klaus-Peter, Siewert Stefan, Öner Alper Ö, Ince Hüseyin, Grabow Niels
Publikováno v:
Current Directions in Biomedical Engineering, Vol 6, Iss 3, Pp 217-220 (2020)
Mitral regurgitation (MR) is the most prevalent valvulopathy in the USA and the second most prevalent valvulopathy in Europe. Despite excellent clinical results of surgical mitral valve repair (SMVR), transcatheter-based mitral valve repair (MVR) pro
Externí odkaz:
https://doaj.org/article/b63a93697e1a42cb8d11984e1ac8550f
Autor:
Rosam Paula, Borowski Finja, Stiehm Michael, Schmitz Klaus Peter, Keiler Jonas, Wree Andreas, Öner Alper Ö, Schmidt Wolfram
Publikováno v:
Current Directions in Biomedical Engineering, Vol 6, Iss 3, Pp 442-445 (2020)
The expansion capacity and accessibility of the side branch is essential for the stenting of complex bifurcations. Since previous measurement methods only provide limited information based on geometrical data of stent cells, a new measurement approac
Externí odkaz:
https://doaj.org/article/c732a82843944a548da9bf74ecc3730e
Autor:
Stiehm Michael, Borowski Finja, Kaule Sebastian, Ott Robert, Pfensig Sylvia, Siewert Stefan, Schmitz Klaus-Peter, Öner Alper Ö, Grabow Niels
Publikováno v:
Current Directions in Biomedical Engineering, Vol 5, Iss 1, Pp 123-126 (2019)
Although the development of the transcatheter aortic valve (TAV) has saved many lives of inoperable patients and has a very good clinical outcome, concerns about valve thrombosis are increasing. Due to the potential risk of late clinically relevant e
Externí odkaz:
https://doaj.org/article/a0dcc4e1b2eb4bceac7199f098b3fd0b
Autor:
Oldenburg Jan, Borowski Finja, Schmitz Klaus-Peter, Stiehm Michael, Öner Alper Ö, Quirin Lukas, John Kristine, Bruschewski Martin, Grundmann Sven
Publikováno v:
Current Directions in Biomedical Engineering, Vol 5, Iss 1, Pp 77-80 (2019)
The formation of a thrombus is associated with dramatic consequences for the patient, such as increased risks of neurologic events and myocardial infarction or even death. A pathologically altered blood flow is associated with these complications. Co
Externí odkaz:
https://doaj.org/article/0ab0a021796d4b55a2c94f6cd4183fcd
Autor:
Borowski Finja, Kaule Sebastian, Siewert Stefan, Schmitz Klaus-Peter, Stiehm Michael, Öner Alper Ö, Grabow Niels
Publikováno v:
Current Directions in Biomedical Engineering, Vol 5, Iss 1, Pp 461-463 (2019)
The implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reducti
Externí odkaz:
https://doaj.org/article/813b57d5863d4ed0a584f4dd003794d9
Autor:
Robert Ott, Alper Ö Öner, Paul Hermann Bellé, Finja Borowski, Klaus-Peter Schmitz, Michael Stiehm
Publikováno v:
Current Directions in Biomedical Engineering, Vol 7, Iss 2, Pp 605-608 (2021)
Mitral regurgitation (MR) is the second most frequent indication for heart valve surgery and catheter interventions. According to European and US-American guidelines, transcatheter mitral valve repair in general and transcatheter edge-to-edge repair
Autor:
Finja Borowski, Sebastian Kaule, Stefan Siewert, Klaus-Peter Schmitz, Michael Stiehm, Alper Ö Öner, Niels Grabow
Publikováno v:
Current Directions in Biomedical Engineering, Vol 5, Iss 1, Pp 461-463 (2019)
The implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reducti
Publikováno v:
Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi. Aug2013, Vol. 13 Issue 5, p473-479. 7p.
Autor:
Başaran AE; Division of Pediatric Pulmonology, Akdeniz University School of Medicine, Antalya, Turkey., Başaran A; Department of Pediatrics, Akdeniz University School of Medicine, Antalya, Turkey., Kocacik Uygun DF; Department of Pediatrics, Division of Allergy Immunology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Yılmaz E; Department of Medical Biology and Genetics, Akdeniz University, Faculty of Medicine, Antalya, Turkey., Moballegh A; Department of Medical Biology and Genetics, Akdeniz University, Faculty of Medicine, Antalya, Turkey., Öz L; Department of Pediatrics, Akdeniz University, Faculty of Medicine, Antalya, Turkey., Alper Ö; Department of Medical Biology and Genetics, Akdeniz University, Faculty of Medicine, Antalya, Turkey., Bingöl A; Division of Pediatric Pulmonology, Akdeniz University School of Medicine, Antalya, Turkey.
Publikováno v:
Turkish thoracic journal [Turk Thorac J] 2021 Nov; Vol. 22 (6), pp. 426-431.